Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (5756)	1/2/2020 10:12:36 AM
From: richardred	Read Replies (1) \| Respond to of 7238

FWIW- I like the ENZ new board member choice on the ENZ board. 8K ENZ named Rebecca J. Fischer to its board of directors. Ms. Fischer is currently the chief financial officer of Bellevue Hospital in New York City. IMO this give some leverage to get their platform started. Co. PR>We have a validated platform that reduces costs significantly, we have been granted approval by New York State for a broad menu of diagnostic tests on our platforms and we have gained acceptance in the marketplace for our model. We are proceeding with the FDA and European Community to secure approvals to fully commercialize. I doubt this would have happened without *Harbert 10%+ owner* pushing hard. IMO the board is very capable in the product development pipeline, but lacks in execution of it's pipeline. I think having at least having a partial truce with Harbert and letting them have one board seat could be a possible solution?

To: richardred who wrote (5756)	1/2/2020 11:02:40 AM
From: richardred	Read Replies (2) \| Respond to of 7238

First buy of the new year. An add to MDWD on some positive news- Small gain at the open. I waited till after I saw the 35,000+ block at asked not going through, and the stock faded soon afterward. Most likely Still two years away from FDA approval in the US for NexoBrid. newsquantified.com